Novanta Inc
$ 137.44
-3.47%
24 Feb - close price
- Market Cap 5,121,926,000 USD
- Current Price $ 137.44
- High / Low $ 149.95 / 136.27
- Stock P/E 96.86
- Book Value 22.36
- EPS 1.47
- Next Earning Report 2026-02-24
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.07 %
- 52 Week High 153.20
- 52 Week Low 98.27
About
Novanta Inc. designs, manufactures, markets and sells precision motion, vision and photonics components and subsystems to original equipment manufacturers in the medical and industrial markets worldwide. The company is headquartered in Bedford, Massachusetts.
Analyst Target Price
$154.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-02-26 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-28 | 2023-11-07 | 2023-08-08 | 2023-05-09 |
| Reported EPS | 0.91 | 0.87 | 0.76 | 0.587 | 0.76 | 0.85 | 0.73 | 0.74 | 0.63 | 0.85 | 0.8 | 0.74 |
| Estimated EPS | 0.9067 | 0.84 | 0.73 | 0.6733 | 0.7133 | 0.85 | 0.69 | 0.58 | 0.63 | 0.74 | 0.73 | 0.64 |
| Surprise | 0.0033 | 0.03 | 0.03 | -0.0863 | 0.0467 | 0 | 0.04 | 0.16 | 0 | 0.11 | 0.07 | 0.1 |
| Surprise Percentage | 0.364% | 3.5714% | 4.1096% | -12.8175% | 6.547% | 0% | 5.7971% | 27.5862% | 0% | 14.8649% | 9.589% | 15.625% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-24 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.88 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NOVT
2026-02-24 22:52:54
Novanta (NASDAQ: NOVT) CFO Robert Buckley sold 1,423 shares of company stock on February 20th for approximately $200,472, reducing his stake by 1.49%. This sale follows a similar transaction on January 21st and comes amid mixed Q4 results, where EPS beat expectations but revenue slightly missed, and Q1 guidance was below street expectations. Despite institutional investors increasing their holdings, the stock trades at a high P/E ratio, and analysts maintain a consensus "Hold" rating.
2026-02-24 18:52:54
Novanta (NOVT) aims for 4%-6% organic revenue growth by 2026, supported by strong order backlogs and innovative product introductions. The company also highlighted a substantial acquisition capacity of $1.5 billion, indicating a strategy for future inorganic growth. These projections were presented during its inaugural Investor Day event.
2026-02-24 18:52:54
Novanta Inc (NOVT) reported record revenue in Q4 2025, with 9% reported growth and 25% year-over-year bookings increase, indicating strong demand. The company outlined ambitious growth strategies for 2026, including plans for double-digit reported revenue growth through acquisitions and strong positioning in high-growth markets. Despite positive performance, gross margins and operating cash flow were lower than expected due to prioritization of customer deliveries and temporary impacts on EPS from recent fundraising and employee equity grants.
2026-02-23 22:35:27
Novanta Inc. announced its fourth-quarter financial results, reporting a profit of $17.5 million and adjusted earnings of $0.91 per share, exceeding Wall Street expectations. The company generated $258.3 million in revenue for the quarter and $980.6 million for the full year. Novanta also provided an outlook for the upcoming first quarter and the entire fiscal year, projecting continued growth in earnings and revenue.
2026-02-23 22:16:06
Novanta Inc. reported a fourth-quarter profit of $17.5 million, or 45 cents per share, surpassing Wall Street expectations when adjusted for non-recurring costs at 91 cents per share. The company's revenue for the period was $235.3 million. For the full year, Novanta's profit reached $33.8 million on revenue of $980.6 million, and it anticipates first-quarter earnings and revenue to fall within specific ranges, with full-year earnings projected between $3.50 and $3.75 per share on revenue of $1.03 billion to $1.05 billion.
2026-02-23 22:05:27
Novanta Inc. (NOVT) has released its 2025 10-K report, detailing a 3.3% revenue increase to $980.6 million, though net income and EPS decreased. The company highlighted growth in its Automation Enabling Technologies and Medical Solutions segments, driven by acquisitions and new product development, despite facing challenges like increased operating costs and macroeconomic headwinds. Novanta plans to achieve sustainable growth through increased medical sales, expansion into high-growth industrial applications, strategic acquisitions, and operational efficiency improvements, while addressing risks like market competition, supply chain disruptions, and geopolitical factors.
